scholarly journals Effect of drug loading and laser surface melting on drug release profile from biodegradable polymer

2013 ◽  
pp. n/a-n/a ◽  
Author(s):  
Shan-Ting Hsu ◽  
Y. Lawrence Yao
Keyword(s):  
Drug Release ◽  
Biodegradable Polymer ◽  
Drug Loading ◽  
Surface Melting ◽  
Release Profile ◽  
Laser Surface ◽  
Laser Surface Melting ◽  
Drug Release Profile

scholarly journals Drug Release from a Spherical Matrix: Theoretical Analysis for a Finite Dissolution Rate Affected by Geometric Shape of Dispersed Drugs

Pharmaceutics ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 582
Author(s):  
Yung-Sheng Lin ◽  
Ruey-Yug Tsay
Keyword(s):  
Drug Release ◽  
Release Rate ◽  
Shape Factor ◽  
Numerical Solutions ◽  
Drug Loading ◽  
Spherical Geometry ◽  
Detailed Comparison ◽  
Release Profile ◽  
Drug Release Profile ◽  
Drug Release Rate

Amending the neglect of finite dissolution in traditional release models, this study proposed a more generalized drug release model considering the simultaneous dissolution and diffusion procedure from a drug-loaded spherical matrix. How the shape factor (n = 0, 1/2, and 2/3 for the planar, cylindrical, and spherical geometry, respectively) of dispersed drug particles affected the release from the matrix was examined for the first time. Numerical solutions of this generalized model were validated by consensus with a short-time analytical solution for planar drugs and by the approach of the diffusion-controlled limits with Higuchi’s model. The drug release rate increases with the ratio of dissolution/diffusion rate (G) and the ratio of solubility/drug loading (K) but decreases with the shape factor of drug particles. A zero-order release profile is identified for planar drugs before starting the surface depletion layer, and also found for cylindrical and spherical dispersed drugs when K and G are small, i.e. the loaded drug is mainly un-dissolved and the drug release rate is dissolution-controlled. It is also shown that for the case of a small G value, the variation of drug release profile, due to the drug particle geometry, becomes prominent. Detailed comparison with the results of the traditional Higuchi’s model indicates that Higuchi’s model can be applied only when G is large because of the assumption of an instantaneous dissolution. For K = 1/101–1/2, the present analysis suggests an error of 33–85% for drug release predicted by Higuchi’s model for G = 100, 14–44% error for G = 101, while a less than 5% error for G ≧ 103.

scholarly journals Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug

2012 ◽  
Vol 9 (75) ◽  
pp. 2437-2449 ◽  
Author(s):  
Adam Bohr ◽  
Jakob Kristensen ◽  
Mark Dyas ◽  
Mohan Edirisinghe ◽  
Eleanor Stride
Keyword(s):  
Drug Release ◽  
Oral Delivery ◽  
Drug Loading ◽  
Chemical Properties ◽  
Processing Parameters ◽  
Solute Concentration ◽  
Release Profile ◽  
Drug Release Profile ◽  
Physico Chemical ◽  
Dissolution Apparatus

Poly(lactic-co-glycolic acid) (PLGA) microspheres containing celecoxib were prepared via electrospraying, and the influence of three processing parameters namely flow rate, solute concentration and drug loading, on the physico-chemical properties of the particles and the drug-release profile was studied. Microspheres with diameters between 2 and 8 μm were produced and a near-monodisperse size distribution was achieved (polydispersivity indices of 6–12%). Further, the inner structure of the particles showed that the internal porosity of the particles increased with increasing solvent concentration. X-ray powder diffraction (XRPD) analysis indicated that the drug was amorphous and remained stable after eight months of storage. Drug release was studied in USP 2 (United States Pharmacopeia Dissolution Apparatus 2) dissolution chambers, and differences in release profiles were observed depending on the parametric values. Changes in release rate were found to be directly related to the influence of the studied parameters on particle size and porosity. The results indicate that electrospraying is an attractive technique for producing drug-loaded microspheres that can be tailored towards an intended drug-delivery application. Compared with the more conventional spray-drying process, it provides better control of particle characteristics and less aggregation during particle formation. In particular, this study demonstrated its suitability for preparing capsules in which the drug is molecularly dispersed and released in a sustained manner to facilitate improved bioavailability.

scholarly journals Studies on the Drug Loading and Release Profiles of Degradable Chitosan-Based Multilayer Films for Anticancer Treatment

Cancers ◽  
2020 ◽  
Vol 12 (3) ◽  
pp. 593 ◽  
Author(s):  
Hyeongdeok Sun ◽  
Daheui Choi ◽  
Jiwoong Heo ◽  
Se Yong Jung ◽  
Jinkee Hong
Keyword(s):  
Drug Release ◽  
Multilayer Film ◽  
Drug Loading ◽  
Building Blocks ◽  
Multilayer Films ◽  
Release Profile ◽  
Layer By Layer ◽  
Drug Release Profile ◽  
Sustained Drug Release ◽  
Release Profiles

This study demonstrates the possibility of developing a rapidly degradable chitosan-based multilayer film for controlled drug release. The chitosan (CHI)-based multilayer nanofilms were prepared with three different types of anions, hyaluronic acid (HA), alginic acid (ALG) and tannic acid (TA). Taking advantage of the Layer-by-Layer (LBL) assembly, each multilayer film has different morphology, porosity and thickness depending on their ionic density, molecular structure and the polymer functionality of the building blocks. We loaded drug models such as doxorubicin hydrochloride (DOX), fluorescein isothiocyanate (FITC) and ovalbumin (Ova) into multilayer films and analyzed the drug loading and release profiles in phosphate-buffered saline (PBS) buffer with the same osmolarity and temperature as the human body. Despite the rapid degradation of the multilayer film in a high pH and salt solution, the drug release profile can be controlled by increasing the functional group density, which results in interaction with the drug. In particular, the abundant carboxylate groups in the CHI/HA film increased the loading amount of DOX and decreased rapid drug release. The TA interaction with DOX via electrostatic interaction, hydrogen bonding and hydrophobic interaction showed a sustained drug release profile. These results serve as principles for fabricating a tailored multilayer film for drug delivery application.

scholarly journals Influence of Terpene Type on the Release from an O/W Nanoemulsion: Experimental and Theoretical Studies

Molecules ◽  
2020 ◽  
Vol 25 (12) ◽  
pp. 2747 ◽  
Author(s):  
Małgorzata Miastkowska ◽  
Paweł Śliwa
Keyword(s):  
Molecular Dynamics ◽  
Drug Release ◽  
Ursolic Acid ◽  
Drug Loading ◽  
In Vitro Release ◽  
Perillyl Alcohol ◽  
Release Profile ◽  
Theoretical Studies ◽  
Drug Release Profile ◽  
Experimental And Theoretical Studies

The interaction between a drug molecule and its carrier’s components is an important factor which influences the drug release profile. For this purpose, molecular dynamics (MD) may be the in silico tool which can help to understand the mechanism of drug loading/release. The aim of this work is to explain the effect of interactions between different types of terpenes, namely perillyl alcohol, forskolin, ursolic acid, and the nanoemulsion droplet core, on the release by means of experimental and theoretical studies. The basic nanoemulsion was composed of caprylic/capric triglyceride as the oil phase, polysorbate 80 as the emulsifier, and water. The in vitro release tests from a terpene-loaded nanoemulsion were carried out to determine the release profiles. The behavior of terpenoids in the nanoemulsion was also theoretically investigated using the molecular dynamics method. The forskolin-loaded nanoemulsion showed the highest percentage of drug release (almost 80% w/w) in contrast to ursolic acid and perillyl alcohol-loaded nanoemulsions (about 53% w/w and 19% w/w, respectively). The results confirmed that the kinetic model of release was terpene-type dependent. The zero-order model was the best to describe the ursolic acid release profile, while the forskolin and the perillyl alcohol followed a first-order and Higuchi model, respectively. Molecular dynamics simulations, especially energetical analysis, confirmed that the driving force of terpenes diffusion from nanoemulsion interior was their interaction energy with a surfactant.

scholarly journals Development and Characterization of a Theranostic Micelles System using TPGS with Docetaxel and Coumarin-6: A Dual Polymeric Nanocarrier System

2018 ◽  
Vol 5 (1) ◽  
pp. 99-108
Author(s):  
L.H. Ching ◽  
S. Mahmood ◽  
R. Edros ◽  
R.V. Kutty
Keyword(s):  
Drug Release ◽  
Early Stage ◽  
Drug Loading ◽  
Release Profile ◽  
Drug Release Profile ◽  
In Vitro Drug Release ◽  
Dual Modality ◽  
Coumarin 6 ◽  
Polymeric Nanocarrier

Theranostic micelles and polymeric nanocarrier-based drug delivery system are well known techniques that involve a diagnostic agent in polymeric micelles for a combination of therapy by using a co-delivery approach which can help in detection of a cancer cell in an early stage, increase killing effect and suppress multi-drug resistance (MDS) for better therapeutic effectiveness. The aim of this study is to develop a dual modality micellar system using D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) as a nanocarrier for co-delivery of docetaxel as a model chemotherapeutic drug and coumarin-6 as a model fluorescence imaging agent for simultaneous cancer imaging and therapy in an early stage. The theranostic micelles were prepared by a solvent casting method and characterized by their particle size, drug loading, drug encapsulation efficiency (EE) and in-vitro drug release profile. These dual modality micellar system TPDC6 micelles were successfully developed with average particle size of 79.59±0.57 nm in diameter and drug loading up to 15.46±1.02 % (EE of 78.99±1.26%) and 9.83±0.76 % (EE of 36.20±0.89%) for docetaxel and coumarin-6 respectively. Besides, the in-vitro drug release profile of the micelles revealed a desired sustained and controlled drug release manner for both docetaxel (21.62±0.36%) and coumarin-6 (10.70±0.46%). In conclusion, the micelles size obtained is in the favourable range for passive targeting through enhanced permeability and retention (EPR) effect and the drug loading and encapsulation efficiency attained are adequate for therapy and diagnosis purposes on cancer cells. This dual modality system is taking great advantages for tumour imaging and inhibition of tumour growth which is very important for early cancer detection.

scholarly journals Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent

2019 ◽  
Vol 20 (7) ◽  
pp. 1531 ◽  
Author(s):  
Seyed Alavi ◽  
Sitah Muflih Al Harthi ◽  
Hasan Ebrahimi Shahmabadi ◽  
Azim Akbarzadeh
Keyword(s):  
Lung Cancer ◽  
Drug Release ◽  
Drug Loading ◽  
Release Profile ◽  
Therapeutic Effects ◽  
Drug Release Profile ◽  
Standard Drug ◽  
Loading Efficiency ◽  
Drug Loading Efficiency

This study aims to improve the cytotoxicity and potency of cisplatin-loaded polybutylcyanoacrylate (PBCA) nanoparticles (NPs) for the treatment of lung cancer through the modulation of temperature and polyethylene glycol (PEG) concentration as effective factors affecting the NPs’ properties. The NPs were synthesized using an anionic polymerization method and were characterized in terms of size, drug loading efficiency, drug release profile, cytotoxicity effects, drug efficacy, and drug side effects. In this regard, dynamic light scattering (DLS), scanning electron microscopy (SEM), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) methods, and hematoxylin and eosin (H&E) staining were used. The results showed that the size and the drug loading efficiency of the synthesized spherical NPs were 355–386 nm and 14–19%, respectively. Also, the drug release profile showed a controlled and slow drug release pattern with approximately 10% drug release over 48 h. In addition, the NPs significantly increased the cytotoxicity of the cisplatin in vitro environment by approximately 2 times and enhanced the therapeutic effects of the drug in vivo environment by increasing the survival time of lung-cancer-bearing mice by 20% compared to the standard drug receiver group. Also, the nanoformulation decreased the drug toxicity in an in vivo environment. According to the results, increasing the temperature and PEG concentration improved the properties of the drug loading efficiency, drug release profile, and cytotoxicity effect of drug-loaded NPs. Consequently, the synthesized formulation increased the survival of tumor-bearing mice and simultaneously decreased the cisplatin toxicity effects. In conclusion, the prepared nanoformulation can be considered a promising candidate for further evaluation for possible therapeutic use in the treatment of lung cancer.

scholarly journals Preparation of Silymarin–quercetin Loaded Nanoparticles by Spontaneous Emulsification Solvent Diffusion Method Using D-alpha-tocopheryl Poly (Ethylene Glycol) 1000 Succinate

2021 ◽  
pp. 84-94
Author(s):  
S. Senthila ◽  
P. Manoj Kumar ◽  
P. Venkatesan
Keyword(s):  
Electron Microscopy ◽  
Drug Release ◽  
Ethylene Glycol ◽  
Encapsulation Efficiency ◽  
Drug Loading ◽  
Release Profile ◽  
Poly Ethylene Glycol ◽  
Drug Release Profile ◽  
Spontaneous Emulsification ◽  
Poly Ethylene

Silymarin, a flavonolignan, derived from Silybum marianum, family Asteraceae has long been used as a hepatoprotective remedy. Silymarin has cytoprotective activities due to its antioxidant property and free radical scavenging activity. The pharmacokinetic studies of past three decades revealed that silymarin has poor absorption, rapid metabolism especially by Phase II metabolism and ultimately poor oral bioavailability. Quercetin, a flavonoid present in edible vegetables and fruits, It is a potent antioxidant and shows a wide range of biological functions. Quercetin improves blood levels and efficacy of number of drugs since it is P-Glycoprotein inhibitor and also inhibits drug metabolizing enzymes. Both silymarin and quercetin were, poorly soluble in the water shows low bioavailability. The advanced type of formulation like polymeric nanoparticles (PNPs) can be successfully utilised for bioavailability enhancement and targeting the Silymarin-quercetin to hepatocytes. A controlled release PNPs of silymarin-quercetin were prepared by spontaneous emulsification solvent diffusion (SESD) method using Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable polymer, D-alpha-tocopheryl poly (ethylene glycol) 1000 succinate (TPGS) used as a solubilizer, as an emulsifier. TPGS as an emulsifier and further as a matrix material blended with PLGA was used to enhance the encapsulation efficiency and improve the drug release profile of nanoparticles. Different formulations with various drug: polymer ratios and volume and concentration of surfactant, centrifugation time were evaluated. The effect of formulation parameters such as drug/polymer ratio, volume and surfactant content were evaluated. The surface morphology and size of the nanoparticles were studied by scanning electron microscopy (SEM) Transmission electron microscopy (TEM). Drug encapsulation efficiency and in vitro drug release profiles of nanoparticles were determined using UV spectrophotometry. The nanoparticles prepared with combination of both the drugs in this study were spherical with size range of 100–200 nm. It was shown that TPGS was a good emulsifier for producing nanoparticles of hydrophobic drugs and improving the encapsulation efficiency and drug loading and drug release profile of nanoparticles. Although the amount of the TPGS used had a significant effect on the nanoparticle size and morphology, the drug loading and release profile of nanoparticles

scholarly journals Comparative Study of Chitosan and Carboxy Methyl Chitosan Nanoparticles in Mefenamic Acid Drug Delivery

2020 ◽  
Vol 10 (3) ◽  
pp. 83-96
Author(s):  
Parankusham Vedavahini ◽  
Chintha Sailu
Keyword(s):  
Drug Release ◽  
Mefenamic Acid ◽  
Dosage Form ◽  
Drug Loading ◽  
Chitosan Nanoparticles ◽  
Entrapment Efficiency ◽  
Release Profile ◽  
Drug Release Profile ◽  
Duration Of Action ◽  
Carboxy Methyl

Nanoparticle based technologies improve the efficiency and speed of already existing processes.The larger size materials and reagents which are in reactive form, can be nanosized to give efficient output. Chitosan and the carboxy methyl chitosan nanoparticles were prepared by using solvent evaporation nanoprecpitation method, loaded with mefenamic acid, (anthranilic acid derivative) a poorly aqueous soluble drug. Mefenamic acid, if used as conventional dosage form, duration of action was 6 hours; when the drug loaded into Chitosan and the carboxy methyl chitosan nanoparticles the drug release profile was up to 26hrs. The particle size, entrapment efficiency, poly dispersity index, drug loading, drug release profiles of mefenamic acid were compared for both nanoparticles and it was observed that carboxy methyl chitosan nanoparticles released mefenamic acid more effectively than chitosan nanoparticles. Keywords: Nanoparticles, Chitosan, Carboxy methyl chitosan, Mefenamic acid

scholarly journals Fabrication and Characterisation of Lavender Oil and Plant Phospholipid Based Sumatriptan Succinate Hybrid Nano Lipid Carriers

2020 ◽  
Author(s):  
Rashid Mehmood Reeta ◽  
Maria John ◽  
Amaldoss Newton
Keyword(s):  
Drug Release ◽  
Zeta Potential ◽  
Central Composite Design ◽  
Drug Loading ◽  
Release Profile ◽  
Membrane Diffusion ◽  
Drug Release Profile ◽  
Lavender Oil ◽  
Sumatriptan Succinate ◽  
Central Composite

Background: Nanostructured Lipid Carriers (NLCs) of Sumatriptan Succinate (SS) were prepared by using lavender oil. In ancient days, lavender oil was used for the treatment of a migraine. The natural anti-migraine agent, lavender oil, combined with an anti-migraine drug such as SS in a nano-formulation, will be a practical alternative approach in migraine therapy. Objectives: Of sumatriptan succinate were fabricated by using a natural anti-migraine oil (lavender oil), LECIVA-S70, which is a specialized grade for liposomal dermatological preparation and designed for emulsion, fat infusions, nutraceutical formulations, and parenteral use. It contains 70% phosphatidylcholine, which is not generally present in the regular soy lecithin. Methods: The central composite design technique was used to examine the relationship between independent variables and responses such as lavender oil and LECIVA-S70. The dependent variables were Z-average (R1), Polydispersity Index (PDI) (R2), and % entrapment efficiency (R3). The NLCs were prepared with the double emulsification technique. The Fourier transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry analyzed the drug excipient compatibility profile. The developed NLCs were characterized for particle size by using Mastersizer, Zetasizer, and Transmission Electron Microscopy TEM). The membrane diffusion technique studied the in vitro drug release profile. Results: The Mean±SD size of the NLCs ranged from 411.4±311.1 d.nm to 398.8±242.6 d.nm. The best formulation (SNE9) demonstrated an average diameter of 398.8±242.6 d.nm, with the PDI of 0.216, and zeta potential of 17.18 mV Conclusion: The optimized formula demonstrated the narrow size range, a satisfactory zeta potential, high drug loading, and reproducible drug release profile. The NLCs successfully retained the aroma of the lavender oil. According to ANOVA, the PDI (R2) is significant with the central composite design.

Sign in / Sign up

Export Citation Format

Share Document